Matching slides 14,162
Current window 9,841-9,870
Pages 473
Rows per page 30
Slide function: Expose Contradictionclear collectionreset all

Slide function

9,841-9,870 of 14,162

filter-aware
146
Uses yellow highlighting to emphasize key claims of deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
147
Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
148
Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
150
Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
151
Uses expert quotes to undermine the company's core product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
152
Uses KOL testimonials to highlight a technical contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
153
Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
154
Uses direct quotes from KOLs to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
155
The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
156
The slide uses historical data to undermine the company's 'innovation' narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
157
Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
158
Uses a series of quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
159
Uses expert quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
161
The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
163
Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
165
Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
167
Uses multiple KOL quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
172
Uses a direct quote from a KOL to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
173
Uses expert testimonials to debunk company growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit